{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:42:21Z","timestamp":1791229341249,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.semarthrit.2007.10.015","type":"journal-article","created":{"date-parts":[[2008,1,28]],"date-time":"2008-01-28T12:09:12Z","timestamp":1201522152000},"page":"188-194","source":"Crossref","is-referenced-by-count":36,"title":["Intravenous Gammaglobulin and Thalidomide May Be an Effective Therapeutic Combination in Refractory Scleromyxedema: Case Report and Discussion of the Literature"],"prefix":"10.1016","volume":"38","author":[{"given":"Petros","family":"Efthimiou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.semarthrit.2007.10.015_bib1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.clindermatol.2006.07.011","article-title":"Scleromyxedema","volume":"24","author":"Cokonis Georgakis","year":"2006","journal-title":"Clin Dermatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2007.10.015_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-4362.2003.01565.x","article-title":"Scleromyxedema revisited","volume":"42","author":"Pomann","year":"2003","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2007.10.015_bib3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1067\/mjd.2001.111630","article-title":"Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema","volume":"44","author":"Rongioletti","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.semarthrit.2007.10.015_bib4","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1365-4362.1989.tb02437.x","article-title":"Scleromyxedema","volume":"28","author":"Harris","year":"1989","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2007.10.015_bib5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0190-9622(95)90007-1","article-title":"Scleromyxedema","volume":"33","author":"Dinneen","year":"1995","journal-title":"J Am Acad Dermatol"},{"issue":"5 Pt. 2","key":"10.1016\/j.semarthrit.2007.10.015_bib6","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0190-9622(00)90274-3","article-title":"Scleromyxedema with dermato-neuro syndrome","volume":"42","author":"Gonzalez","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2007.10.015_bib7","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00000372-200110000-00001","article-title":"Nephrogenic fibrosing dermopathy","volume":"23","author":"Cowper","year":"2001","journal-title":"Am J Dermatopathol"},{"issue":"5","key":"10.1016\/j.semarthrit.2007.10.015_bib8","first-page":"549","article-title":"Scleromyxedema","volume":"24","author":"Chanda","year":"1979","journal-title":"Cutis"},{"key":"10.1016\/j.semarthrit.2007.10.015_bib9","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1001\/archderm.1964.01590270132030","article-title":"An abnormal serum globulin in lichen myxedematosus","volume":"89","author":"McCarthy","year":"1964","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2007.10.015_bib10","first-page":"89","article-title":"Scleromyxedema: successful treatment of cutaneous and neurologic symptoms","volume":"65","author":"Nieves","year":"2000","journal-title":"Cutis"},{"issue":"1","key":"10.1016\/j.semarthrit.2007.10.015_bib11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/archderm.99.1.51","article-title":"Scleromyxedema","volume":"99","author":"Feldman","year":"1969","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2007.10.015_bib12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1001\/archderm.115.3.295","article-title":"Treatment of scleromyxedema with melphalan","volume":"115","author":"Harris","year":"1979","journal-title":"Arch Dermatol"},{"issue":"2 Pt. 2","key":"10.1016\/j.semarthrit.2007.10.015_bib13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0190-9622(99)70383-X","article-title":"Scleromyxedema","volume":"41","author":"Bata-Csorgo","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.semarthrit.2007.10.015_bib14","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1365-4362.1978.tb05989.x","article-title":"Lichen myxedematosus","volume":"17","author":"Jessen","year":"1978","journal-title":"Int J Dermatol"},{"issue":"10","key":"10.1016\/j.semarthrit.2007.10.015_bib15","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1001\/archderm.111.10.1325","article-title":"Lich myxedematosus","volume":"111","author":"Howsden","year":"1975","journal-title":"Arch Dermatol"},{"issue":"2 Pt. 2","key":"10.1016\/j.semarthrit.2007.10.015_bib16","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0190-9622(96)90650-7","article-title":"Treatment of scleromyxedema with 2-chlorodeoxyadenosine","volume":"35","author":"Davis","year":"1996","journal-title":"J Am Acad Dermatol"},{"issue":"2 Pt. 1","key":"10.1016\/j.semarthrit.2007.10.015_bib17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0190-9622(84)80230-3","article-title":"Treatment of scleromyxedema with etretinate","volume":"10","author":"Brenner","year":"1984","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2007.10.015_bib18","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0190-9622(88)70199-1","article-title":"Scleromyxedema: therapeutic response to isotretinoin in three patients","volume":"19","author":"Milam","year":"1988","journal-title":"J Am Acad Dermatol"},{"issue":"5 Pt. 2","key":"10.1016\/j.semarthrit.2007.10.015_bib19","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/0190-9622(91)70132-L","article-title":"Improvement of scleromyxedema associated with isotretinoin therapy","volume":"24","author":"Hisler","year":"1991","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2007.10.015_bib20","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/archderm.123.6.786","article-title":"Plasmapheresis in a patient with scleromyxedema","volume":"123","author":"Westheim","year":"1987","journal-title":"Arch Dermatol"},{"issue":"5 Pt. 1","key":"10.1016\/j.semarthrit.2007.10.015_bib21","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0190-9622(08)81176-0","article-title":"Successful treatment of scleromyxedema with plasmapheresis and immunosuppression","volume":"22","author":"Keong","year":"1990","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2007.10.015_bib22","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2133.1987.tb07499.x","article-title":"Scleromyxoedema\u2014successful treatment with plasma exchange and immunosuppression","volume":"117","author":"Macfarlane","year":"1987","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.semarthrit.2007.10.015_bib23","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1001\/archderm.127.11.1733","article-title":"Regression of scleromyxedema with topical betamethasone and dimethyl sulfoxide: a 30-month follow-up","volume":"127","author":"Bonnetblanc","year":"1991","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2007.10.015_bib24","doi-asserted-by":"crossref","first-page":"481","DOI":"10.4065\/74.5.481","article-title":"Scleromyxedema: a complete response to prednisone","volume":"74","author":"Rayson","year":"1999","journal-title":"Mayo Clin Proc"},{"issue":"2 Suppl","key":"10.1016\/j.semarthrit.2007.10.015_bib25","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1016\/j.jaad.2004.03.023","article-title":"A complete and durable clinical response to high-dose dexamethasone in a patient with scleromyxedema","volume":"51","author":"Horn","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2007.10.015_bib26","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jaad.2005.04.012","article-title":"High-dose dexamethasone in scleromyxedema: report of 2 additional cases","volume":"53","author":"Kreuter","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2007.10.015_bib27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1346-8138.2006.00047.x","article-title":"Scleromyxedema: an experience using treatment with systemic corticosteroid and review of the published work","volume":"33","author":"Lin","year":"2006","journal-title":"J Dermatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2007.10.015_bib28","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1001\/archderm.140.3.277","article-title":"Thalidomide as a potential treatment for scleromyxedema","volume":"140","author":"Caradonna","year":"2004","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2007.10.015_bib29","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jaad.2004.01.058","article-title":"Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients","volume":"51","author":"Sansbury","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2007.10.015_bib30","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000096914","article-title":"Scleromyxedema: successful treatment with thalidomide in two patients","volume":"214","author":"Amini-Adle","year":"2007","journal-title":"Dermatology"},{"issue":"10","key":"10.1016\/j.semarthrit.2007.10.015_bib31","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1111\/j.1468-3083.2006.01761.x","article-title":"Successful treatment of scleromyxedema using thalidomide","volume":"20","author":"Thyssen","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.semarthrit.2007.10.015_bib32","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000093856","article-title":"Scleromyxedema, a positive effect with thalidomide","volume":"213","author":"Jacob","year":"2006","journal-title":"Dermatology"},{"issue":"2 Pt. 2","key":"10.1016\/j.semarthrit.2007.10.015_bib33","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0190-9622(00)70305-7","article-title":"Scleromyxedema: response to hih-dose intravenous immunoglobulin (hdIVIg)","volume":"43","author":"Lister","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2007.10.015_bib34","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1468-3083.2005.01134.x","article-title":"Tumorous variant of scleromyxedema","volume":"19","author":"Wojas-Pelc","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.semarthrit.2007.10.015_bib35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10227-005-0137-9","article-title":"Combination oral prednisone and intravenous immunoglobulin in the treatment of scleromyxedema","volume":"9","author":"Majeski","year":"2005","journal-title":"J Cutan Med Surg"},{"issue":"3","key":"10.1016\/j.semarthrit.2007.10.015_bib36","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2230.2004.01518.x","article-title":"Successful treatment of scleromyxoedema with high dose intravenous immunoglobulin","volume":"29","author":"Karim","year":"2004","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2007.10.015_bib37","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1365-2133.2003.05682.x","article-title":"Scleromyxoedema: treatment of cutaneous and systemic manifestations with high-dose intravenous immunoglobulin","volume":"149","author":"Kulczycki","year":"2003","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2007.10.015_bib38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/ard.61.1.59","article-title":"Intravenous immunoglobulins control scleromyxoedema","volume":"61","author":"Righi","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.semarthrit.2007.10.015_bib39","first-page":"1071","article-title":"Complete remission of scleromyxedema following autologous stem cell transplantation","volume":"137","author":"Feasel","year":"2001","journal-title":"Arch Dermatol"},{"issue":"10","key":"10.1016\/j.semarthrit.2007.10.015_bib40","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1001\/archderm.141.10.1277","article-title":"Successful treatment of scleromyxedema with autologous peripheral blood stem cell transplantation","volume":"141","author":"Lacy","year":"2005","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2007.10.015_bib41","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1182\/blood-2004-12-4870","article-title":"Scleromyxedema: role of high-dose melphalan with autologous stem cell transplantation","volume":"107","author":"Donato","year":"2006","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.semarthrit.2007.10.015_bib42","first-page":"321","article-title":"Scleromyxedema: systemic manifestations and cosmetic improvement from dermabrasion","volume":"39","author":"Kaufman","year":"1987","journal-title":"Cutis"},{"issue":"4","key":"10.1016\/j.semarthrit.2007.10.015_bib43","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/00000637-199810000-00017","article-title":"Scleromyxedema (papular mucinosis): a surgical perspective","volume":"41","author":"Elliott","year":"1998","journal-title":"Ann Plast Surg"},{"issue":"2 Pt. 2","key":"10.1016\/j.semarthrit.2007.10.015_bib44","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0190-9622(99)70471-8","article-title":"Scleromyxedema: treatment with interferon alfa","volume":"40","author":"Tschen","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2007.10.015_bib45","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2133.1982.tb04539.x","article-title":"Electron-beam treatment of scleromyxoedema","volume":"106","author":"Lowe","year":"1982","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2007.10.015_bib46","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2133.1984.tb04642.x","article-title":"PUVA treatment of scleromyxoedema","volume":"110","author":"Farr","year":"1984","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2007.10.015_bib47","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0002-9343(99)00408-8","article-title":"Thalidomide: current and potential clinical applications","volume":"108","author":"Calabrese","year":"2000","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.semarthrit.2007.10.015_bib48","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s004170050106","article-title":"Thalidomide inhibits corneal angiogenesis induced by vascular endothelial growth factor","volume":"236","author":"Kruse","year":"1998","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.semarthrit.2007.10.015_bib49","doi-asserted-by":"crossref","first-page":"708","DOI":"10.4049\/jimmunol.179.1.708","article-title":"Thalidomide prevents bleomycin-induced pulmonary fibrosis in mice","volume":"179","author":"Tabata","year":"2007","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.semarthrit.2007.10.015_bib50","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0190-9622(96)90122-X","article-title":"Rediscovering thalidomide: a review of its mechanism of action, side effects, and potential uses","volume":"35","author":"Tseng","year":"1996","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2007.10.015_bib51","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1160\/TH06-09-0494","article-title":"Thalidomide and thrombosis","volume":"97","author":"El Accaoui","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.semarthrit.2007.10.015_bib52","article-title":"Arterial thrombosis and thalidomide","author":"Goz","year":"2007","journal-title":"J Thromb Thrombolysis"},{"issue":"4","key":"10.1016\/j.semarthrit.2007.10.015_bib53","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1365-2567.2002.01545.x","article-title":"Immunomodulatory action of intravenous immunoglobulin","volume":"107","author":"Sewell","year":"2002","journal-title":"Immunology"},{"issue":"8","key":"10.1016\/j.semarthrit.2007.10.015_bib54","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1080\/08916930601061272","article-title":"Immunomodulation of experimental pulmonary fibrosis by intravenous immunoglobulin (IVIG)","volume":"39","author":"Molina","year":"2006","journal-title":"Autoimmunity"},{"issue":"3","key":"10.1016\/j.semarthrit.2007.10.015_bib55","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1385\/CRIAI:29:3:321","article-title":"Intravenous immunoglobulin and fibrosis","volume":"29","author":"Molina","year":"2005","journal-title":"Clin Rev Allergy Immunol"},{"issue":"6","key":"10.1016\/j.semarthrit.2007.10.015_bib56","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/art.10363","article-title":"The role of intravenous immunoglobulin therapy in mediating skin fibrosis in tight skin mice","volume":"46","author":"Blank","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.semarthrit.2007.10.015_bib57","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/ard.62.2.175","article-title":"Fibrosis regression induced by intravenous gammaglobulin treatment","volume":"62","author":"Amital","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2007.10.015_bib58","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/art.20195","article-title":"Intravenous immunoglobulin modulates cutaneous involvement and reduces skin fibrosis in systemic sclerosis: an open-label study","volume":"50","author":"Levy","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.semarthrit.2007.10.015_bib59","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/rheumatology\/34.6.535","article-title":"Ultrasound measurement of skin thickness in systemic sclerosis","volume":"34","author":"Ihn","year":"1995","journal-title":"Br J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2007.10.015_bib60","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1148\/radiology.189.1.8372222","article-title":"Imaging of the skin with 20-MHz US","volume":"189","author":"Fornage","year":"1993","journal-title":"Radiology"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017207001886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017207001886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T11:59:29Z","timestamp":1557230369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017207001886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0049017207001886"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2007.10.015","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}